Pesquisar
Vir Biotechnology Inc
VIRAdicionar à lista de desejos
10.600USD
-0.320-2.93%
Fechamento 09-18 16:00（ET）
1.79BValor de mercado
PerdaP/L TTM
Mais detalhes de Vir Biotechnology Inc Empresa
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes infectious disease programs for chronic hepatitis delta and chronic hepatitis B infections and multiple dual-masked T-cell engagers across validated targets in solid tumor indications. It also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies. Tobevibart is an investigational neutralizing monoclonal antibody (mAb) that has been engineered for immune engagement and targets a conserved region on the hepatitis B surface antigen (HBsAg). Elebsiran is an investigational HBV-targeted small interfering RNA (siRNA) that reduces HBsAg. Its pipeline includes VIR-5818, VIR-5500, VIR-5525, and HIV Cure. It also has rights to the PRO-XTEN masking platform for oncology and infectious disease.
Vir Biotechnology Inc Perfil
Código da empresaVIR
Nome da EmpresaVir Biotechnology Inc
Data de listagemOct 11, 2019
CEODe Backer (Marianne)
Número de funcionários408
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 11
Endereço1800 Owens Street
CidadeSAN FRANCISCO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94158
Telefone14159064324
Sitehttps://www.vir.bio/
Código da empresaVIR
Data de listagemOct 11, 2019
CEODe Backer (Marianne)
Executivos da empresa Vir Biotechnology Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Marianne De Backer, Ph.D.
Dr. Marianne De Backer, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
233.10K
-15.93%
Dr. Marianne De Backer, Ph.D.
Dr. Marianne De Backer, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
233.10K
-15.93%
Dr. Marianne De Backer, Ph.D.
Dr. Marianne De Backer, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
233.10K
-15.93%
Mr. Brent Sabatini, CPA
Mr. Brent Sabatini, CPA
Interim Principal Financial Officer, Senior Vice President, Chief Accounting Officer
Interim Principal Financial Officer, Senior Vice President, Chief Accounting Officer
57.44K
-0.66%
Mr. Brent Sabatini, CPA
Mr. Brent Sabatini, CPA
Interim Principal Financial Officer, Senior Vice President, Chief Accounting Officer
Interim Principal Financial Officer, Senior Vice President, Chief Accounting Officer
57.44K
-0.66%
Mr. Brent Sabatini, CPA
Mr. Brent Sabatini, CPA
Interim Principal Financial Officer, Senior Vice President, Chief Accounting Officer
Interim Principal Financial Officer, Senior Vice President, Chief Accounting Officer
57.44K
-0.66%
Mr. Robert J. (Bob) More
Mr. Robert J. (Bob) More
Independent Director
Independent Director
32.66K
-24.50%
Mr. Robert J. (Bob) More
Mr. Robert J. (Bob) More
Independent Director
Independent Director
32.66K
-24.50%
Mr. Robert J. (Bob) More
Mr. Robert J. (Bob) More
Independent Director
Independent Director
32.66K
-24.50%
Mr. Jeffrey S. (Jeff) Hatfield
Mr. Jeffrey S. (Jeff) Hatfield
Independent Chairman of the Board
Independent Chairman of the Board
31.81K
+25.15%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Marianne De Backer, Ph.D.
Dr. Marianne De Backer, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
233.10K
-15.93%
Dr. Marianne De Backer, Ph.D.
Dr. Marianne De Backer, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
233.10K
-15.93%
Dr. Marianne De Backer, Ph.D.
Dr. Marianne De Backer, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
233.10K
-15.93%
Mr. Brent Sabatini, CPA
Mr. Brent Sabatini, CPA
Interim Principal Financial Officer, Senior Vice President, Chief Accounting Officer
Interim Principal Financial Officer, Senior Vice President, Chief Accounting Officer
57.44K
-0.66%
Mr. Brent Sabatini, CPA
Mr. Brent Sabatini, CPA
Interim Principal Financial Officer, Senior Vice President, Chief Accounting Officer
Interim Principal Financial Officer, Senior Vice President, Chief Accounting Officer
57.44K
-0.66%
Mr. Brent Sabatini, CPA
Mr. Brent Sabatini, CPA
Interim Principal Financial Officer, Senior Vice President, Chief Accounting Officer
Interim Principal Financial Officer, Senior Vice President, Chief Accounting Officer
57.44K
-0.66%
Perguntas frequentes
Quem são os cinco principais acionistas de Vir Biotechnology Inc?
Os cinco principais acionistas de Vir Biotechnology Inc são: Dr. Marianne De Backer, Ph.D.
Quantas instituições possuem ações da Vir Biotechnology Inc (VIR)?
Em 2026Q1, 497 instituições possuíam ações da Vir Biotechnology Inc, com valor de mercado aproximado de 130.35M, representando 77.29% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 9591956.00.